Literature DB >> 12648733

Association between a promoter variant in the monoamine oxidase A gene and schizophrenia.

Erik G Jönsson1, Nadine Norton, Kaj Forslund, Marja Mattila-Evenden, Gunnar Rylander, Marie Asberg, Michael J Owen, Göran C Sedvall.   

Abstract

Monoaminergic transmission has been implicated in the pathophysiology of schizophrenia. We investigated a putative functional promoter polymorphism in the monoamine oxidase A (MAOA) gene in schizophrenic patients (n=133) and control subjects (n=377). In men, there was an association between the less efficiently transcribed alleles and schizophrenia (chi(2)=4.01, df=1, p<0.05). In women, no significant differences were found. The present results support the involvement of the MAOA gene in men with schizophrenia in the investigated Swedish population but should be interpreted with caution until replicated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648733     DOI: 10.1016/s0920-9964(02)00224-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  17 in total

1.  Sudden infant death syndrome (SIDS) and polymorphisms in Monoamine oxidase A gene (MAOA): a revisit.

Authors:  Maximilian Groß; Thomas Bajanowski; Mechtild Vennemann; Micaela Poetsch
Journal:  Int J Legal Med       Date:  2013-10-31       Impact factor: 2.686

2.  SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.

Authors:  Yunmin Li; Tatsuo Kido; Maria M Garcia-Barcelo; Paul K H Tam; Z Laura Tabatabai; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2014-09-28       Impact factor: 6.150

3.  Evidence of MAOA genotype involvement in spatial ability in males.

Authors:  Sven C Mueller; Brian R Cornwell; Christian Grillon; Jessica Macintyre; Elena Gorodetsky; David Goldman; Daniel S Pine; Monique Ernst
Journal:  Behav Brain Res       Date:  2014-03-23       Impact factor: 3.332

4.  Regulation of monoamine oxidase A by the SRY gene on the Y chromosome.

Authors:  Jason B Wu; Kevin Chen; Yunmin Li; Yun-Fai Chris Lau; Jean C Shih
Journal:  FASEB J       Date:  2009-08-06       Impact factor: 5.191

5.  MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.

Authors:  Zichao Liu; Liang Huang; Xiong-Jian Luo; Lichuan Wu; Ming Li
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

6.  Adaptive evolution of genes underlying schizophrenia.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Proc Biol Sci       Date:  2007-11-22       Impact factor: 5.349

7.  Association study between monoamine oxidase A (MAOA) gene polymorphisms and schizophrenia: lack of association with schizophrenia and possible association with affective disturbances of schizophrenia.

Authors:  Su Kang Kim; Hae Jeong Park; Hosik Seok; Hye Sook Jeon; Joo-Ho Chung; Won Sub Kang; Jong Woo Kim; Gyeong Im Yu; Dong Hoon Shin
Journal:  Mol Biol Rep       Date:  2014-02-09       Impact factor: 2.316

Review 8.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

9.  Towards a neurodevelopmental model of clinical case formulation.

Authors:  Marjorie Solomon; David Hessl; Sufen Chiu; Emily Olsen; Robert L Hendren
Journal:  Psychiatr Clin North Am       Date:  2009-03

10.  Prolactin levels in olanzapine treatment correlate with positive symptoms of schizophrenia: results from an open-label, flexible-dose study.

Authors:  Yi-Lung Chen; Ting-Sheng Cheng; For-Wey Lung
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.